全文获取类型
收费全文 | 8041篇 |
免费 | 505篇 |
国内免费 | 100篇 |
专业分类
耳鼻咽喉 | 92篇 |
儿科学 | 157篇 |
妇产科学 | 228篇 |
基础医学 | 933篇 |
口腔科学 | 279篇 |
临床医学 | 727篇 |
内科学 | 2360篇 |
皮肤病学 | 88篇 |
神经病学 | 658篇 |
特种医学 | 294篇 |
外科学 | 1219篇 |
综合类 | 21篇 |
一般理论 | 1篇 |
预防医学 | 370篇 |
眼科学 | 72篇 |
药学 | 422篇 |
中国医学 | 6篇 |
肿瘤学 | 719篇 |
出版年
2024年 | 14篇 |
2023年 | 138篇 |
2022年 | 266篇 |
2021年 | 492篇 |
2020年 | 282篇 |
2019年 | 324篇 |
2018年 | 363篇 |
2017年 | 254篇 |
2016年 | 301篇 |
2015年 | 309篇 |
2014年 | 405篇 |
2013年 | 468篇 |
2012年 | 653篇 |
2011年 | 587篇 |
2010年 | 321篇 |
2009年 | 318篇 |
2008年 | 445篇 |
2007年 | 398篇 |
2006年 | 376篇 |
2005年 | 306篇 |
2004年 | 266篇 |
2003年 | 230篇 |
2002年 | 190篇 |
2001年 | 74篇 |
2000年 | 59篇 |
1999年 | 70篇 |
1998年 | 51篇 |
1997年 | 26篇 |
1996年 | 35篇 |
1995年 | 28篇 |
1994年 | 24篇 |
1993年 | 19篇 |
1992年 | 39篇 |
1991年 | 37篇 |
1990年 | 37篇 |
1989年 | 48篇 |
1988年 | 42篇 |
1987年 | 36篇 |
1986年 | 36篇 |
1985年 | 31篇 |
1984年 | 17篇 |
1983年 | 12篇 |
1981年 | 11篇 |
1979年 | 23篇 |
1978年 | 15篇 |
1977年 | 16篇 |
1974年 | 16篇 |
1972年 | 12篇 |
1970年 | 14篇 |
1969年 | 10篇 |
排序方式: 共有8646条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.
Thiazolidinediones (TZDs), agonists of the nuclear receptor peroxisome proliferator-activated receptor-γ, induce the expression
of many genes, including several enzymes and transporters involved in glucose and lipid metabolism. Although the efficacy
of TZDs on blood glucose control in type 2 diabetes is not questionable, their cardiovascular effects have been debated, with
beneficial or harmful actions suggested by different authors. This article reviews the available clinical evidence on the
cardiovascular effects of TZDs, discussing possible mechanisms underlying the observed effects and suggesting some directions
for future research. 相似文献
5.
Francesco Landi Ettore Capoluongo Andrea Russo Graziano Onder Matteo Cesari Paola Lulli Angelo Minucci Marco Pahor Cecilia Zuppi Roberto Bernabei 《Growth hormone & IGF research》2007,17(1):58-66
CONTEXT: Increasing evidences from experimental and human studies suggest that the activity of the growth hormone (GH/insulin-like growth factor-I) axis may contribute to the age-related cognitive decline and poor cognition in late life. OBJECTIVE: The aim of the present study was to evaluate the relationship of total serum free IGF-I and its binding protein-3 with cognitive performance in older persons aged 80 years or older. DESIGN: Data are from baseline evaluation of the ilSIRENTE study (n=353). Cognitive performance was evaluated using five items enclosed in the Minimum Data Set for Home Care assessment form: short-term memory, procedural memory, cognitive skills in daily decision making, verbal expression, comprehension. Free insulin-like growth factor-I (free IGF-I) and IGF-binding protein-3 (IGFBP-3) in blood were measured. Analysis of covariance (ANCOVA) was used to examine the relationship between cognitive impairment and the serum free IGF-I and IGFBP-3 concentrations, after adjustment for potential confounding variables. RESULTS: After adjustment for potential confounders, which included age, gender, education, cerebrovascular disease, ischemic heart disease, congestive heart failure, hypertension, diabetes, depression, Parkinson diseases, thyroid diseases, smoking status, alcohol abuse, body mass index, and number of medications, individuals with verbal expression problems (n=20) and individuals with comprehension problems (n=24) had a significantly lower serum levels of readily dissociable IGF-I than participants without cognitive impairments. The serum IGFBP-3 presented the same behavior of free IGF-I. CONCLUSION: The present study suggests that among old-old subjects living in the community lower levels of total serum free IGF-I and IGFBP-3 are associated with impairment of cognitive performance. This finding suggests that the GH/IGF-I axis may play an important role in the age-related decline of cognitive performance. 相似文献
6.
M C L'Huillier D Steschenko D Olive J L Bernard C Raybaud P Schaffer 《Revue d'épidémiologie et de santé publique》1988,36(4-5):301-308
Following the well-known European CCRs of Manchester and Turin, 2 regional CCRs have been recently created in France: in Nancy (1983) and Marseille (1984); both are population based CCRs, covering respectively 535,200 and 809,200 children (0-14 yrs). All malignant neoplasms are included, as well as brain tumours (whatever grading) and borderline malignancies. Data are collected from medical and administrative sources. Registration is active and every source is recontacted annually. The registries contact all physicians who might include children among their patients (private and hospital practice), and laboratories of pathology-cytology. The University Hospital Centers and Anti-Cancer Centers in adjacent regions, and in Paris are contacted. Death certificates for children dying of a malignant neoplasm are also sent to the registry. Data collected are as follows: name, age, sex, address, date and method of diagnosis, histological type, anatomical site, stage, treatment and sources of information. We added the data of a general cancer registry, created in Strasbourg in 1975 and covering 205,900 children. reliability of the methodology is attested by the similarity of the results obtained in other European, US and Australian CCRs. In conclusion, this type of registry is needed to organize multicentric epidemiological studies about the role of etiological factors, the survival, and the long term sequelae. 相似文献
7.
Endovascular repair for concomitant multilevel aortic disease. 总被引:2,自引:0,他引:2
Patrizio Castelli Roberto Caronno Gabriele Piffaretti Matteo Tozzi Chiara Lomazzi Domenico Laganà Gianpaolo Carrafiello Salvatore Cuffari 《European journal of cardio-thoracic surgery》2005,28(3):478-482
OBJECTIVE: Patients with multilevel aortic disease represent a small subgroup with the need for extensive surgical treatment at considerable risk. We present our experience of endovascular exclusion for simultaneous thoracic and abdominal aortic disease in four patients. METHODS: Between January 2002 and January 2005, four patients underwent endovascular repair for simultaneous thoracic and abdominal aortic disease. Mean age was 69+/-10 years (range, 60-81). Thoracic lesions included penetrating aortic ulcer (n=2, ruptured=1), atherosclerotic aneurysm (n=1), and chronic type B dissection (n=1). Abdominal aortic disease included atherosclerotic infrarenal (n=3) and juxtarenal (n=1) aortic aneurysms. Thoracic aortic stent-grafts had been the following: Excluder/TAG (n=3) or Talent (n=1) straight tube devices. Abdominal aortic stent-grafts used were as following: Excluder (n=3) or Zenith (n=1). All patients were followed-up with CT-angiography and chest X-rays 1, 4, 12 months after the procedure, and once per year thereafter. RESULTS: Stent-graft deployment was technically successful in all cases. Intraoperative mortality was not observed. Mean procedure time was 94+/-34 min (range, 70-145). Early postoperative complications occurred in one patient that developed acute renal failure but dialysis was not required. Mean hospitalisation was 8+/-5 days (range, 4-15). Late death occurred in one patient for an undetected ruptured thoracic type 1 endoleak. All three survivors are currently well 16.5 months (range, 3-36) after surgery. No neurological complications developed. CONCLUSION: Simultaneous abdominal and thoracic endovascular repair for multilevel aortic disease is feasible and could be a viable alternative in high-risk patients, who otherwise may not be suitable candidates for conventional repair. 相似文献
8.
9.
10.